Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Inv. presentation
|
CohBar, Inc. (CWBR)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/14/2023 |
8-K
| Quarterly results |
11/08/2022 |
8-K
| Quarterly results |
08/15/2022 |
8-K
| Quarterly results |
05/16/2022 |
8-K
| Quarterly results |
03/29/2022 |
8-K
| Quarterly results |
08/10/2021 |
8-K
| Quarterly results |
05/17/2021 |
8-K
| Quarterly results |
03/30/2021 |
8-K
| Quarterly results |
11/16/2020 |
8-K
| Quarterly results |
08/13/2020 |
8-K
| Quarterly results |
05/14/2020 |
8-K
| Quarterly results |
03/12/2020 |
8-K
| Quarterly results |
11/06/2019 |
8-K
| Quarterly results |
08/07/2019 |
8-K
| Quarterly results |
05/07/2019 |
8-K
| Quarterly results |
03/18/2019 |
8-K
| Quarterly results |
11/14/2018 |
8-K
| Quarterly results |
08/14/2018 |
8-K
| Quarterly results |
05/15/2018 |
8-K
| Quarterly results |
04/02/2018 |
8-K
| Quarterly results |
11/13/2017 |
8-K
| Quarterly results |
08/14/2017 |
8-K
| Quarterly results |
05/15/2017 |
8-K
| Form 8-K - Current report |
03/22/2017 |
8-K
| Form 8-K - Current report |
11/14/2016 |
8-K
| Quarterly results |
08/15/2016 |
8-K
| Quarterly results |
05/13/2016 |
8-K
| Form 8-K - Current report |
03/09/2016 |
8-K
| Form 8-K - Current report |
11/16/2015 |
8-K
| Quarterly results |
08/11/2015 |
8-K
| Quarterly results |
05/15/2015 |
8-K
| Quarterly results
Docs:
|
"CohBar, Inc. Announces First Quarter 2015 Financial Results Menlo Park, California - May 15, 2015 - CohBar, Inc. , an innovative biotechnology company focused on developing mitochondria-based therapeutics to treat diseases associated with aging, today reported financial results for the three months ended March 31, 2015. “We began last quarter with a very successful completion of our initial public offering and concurrent private placement,” said Jon Stern, CohBar CEO, “and have continued to make great progress toward our goal of bringing a mitochondria-based therapeutic to the clinic in 2017. We look forward to providing you with further updates as the year progresses.” Business Highlights and Recent Developments: · Completed Initial Public Offering and Private Placement. On January..." |
|
03/31/2015 |
8-K
| Quarterly results |
|
|